Organisation paid for research Program year 2019 Source: CMS Open Payments

FXM Research International

Neither a doctor nor a teaching hospital

Research payments

$276,425

19 payments

Through program year 2019, FXM Research International is reported as receiving $276,425 in research payments, across 19 payments.

By program year

1 row
Year Kind Amount Payments
2019 Research $276,425 19

Breakdown

Who paid Research payments · program year 2019
  1. Taro Pharmaceuticals USA, Inc. $276,425 19 payments
Studies the money was for Research payments · program year 2019
  1. BTCG 1808 $159,795 9 payments
  2. To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15 Topical Gel $106,475 5 payments
  3. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $4,388 2 payments
  4. CTBC 1705 $4,150 2 payments
  5. TRTC 1912 $1,618 1 payment
What the money was spent on Research payments · program year 2019
  1. Professional salary support $262,175 16 payments
  2. Overhead $7,250 2 payments
  3. Other $7,000 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record